Subscription Agreement Subscription Agreement • March 6th, 2023 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
This Subscription Agreement (this “Agreement”) is entered into as of March 3, 2023 by and between Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), and the investor set forth on the signature page hereto (the “Investor”).
